Derek is responsible for identifying early stage targets, small molecules and monoclonal antibodies for our drug discovery group and the licensing of mature programmes to industry.
Derek Sheader
Latest news
-
Two major UK decisions announced on use of Alzheimer’s drug, lecanemab
Read more: Two major UK decisions announced on use of Alzheimer’s drug, lecanemab -
Drug trial offers hope to 200,000 people with ‘hidden’ lung condition
Read more: Drug trial offers hope to 200,000 people with ‘hidden’ lung condition -
LifeArc funds innovative rare liver disease clinical trial
Read more: LifeArc funds innovative rare liver disease clinical trial -
Charities join forces to transform treatment for children with cancer
Read more: Charities join forces to transform treatment for children with cancer -
AI software tool aims to spot early signs of dementia from brain scans during routine appointments
Read more: AI software tool aims to spot early signs of dementia from brain scans during routine appointments